CR1 and Alzheimer disease: In addition, molecular interactions of genistein against the several other biomarkers of AD identified including complement receptor 1, clusterin, sphingolipids, and so on will further aid for better comprehension of the genistein’s disease-modifying action against AD (Devi et al., 2017).